camptothecin has been researched along with 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahlin, A; Jiang, X; Lu, Q; Tantisira, K; Weiss, ST | 1 |
1 other study(ies) available for camptothecin and 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide
| Article | Year |
|---|---|
A high-throughput chemical screen identifies novel inhibitors and enhancers of anti-inflammatory functions of the glucocorticoid receptor.
Topics: A549 Cells; Amides; Anti-Inflammatory Agents; Camptothecin; Cell Line; Dexamethasone; Drug Evaluation, Preclinical; Drug Repositioning; Drug Synergism; Gene Expression Regulation; Glucocorticoids; Glycogen Synthase Kinase 3 beta; High-Throughput Screening Assays; Humans; NF-kappa B; Protein Kinase Inhibitors; Receptors, Glucocorticoid; Signal Transduction; Small Molecule Libraries; Thiophenes | 2017 |